The Pharmaceutical and Life Sciences Real World Evidence Market is estimated to be valued at USD 2.0 billion in 2024 and is expected to reach USD 5.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 15% from 2024 to 2031. https://www.coherentmi.com/blog/pharmaceutical-and-life-sciences-real-world-evidence-poised-for-significant-growth-126